ArticleDisease markers2021

A Cell Cycle Progression-Derived Gene Signature to Predict Prognosis and Therapeutic Response in Hepatocellular Carcinoma.

Yongfeng Hui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.